Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Published 15/08/2023, 19:01
© Reuters.  Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga - by Lisa Levin, Benzinga Editor. Gainers

  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
  • Delcath Systems, Inc. (NASDAQ: DCTH) shares jumped 85.3% to $5.78 after the company announced FDA approval of HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
  • Tiziana Life Sciences Ltd (NASDAQ: TLSA) surged 40% to $0.8720 after the company announced FDA IND clearance of intranasal foralumab to be studied in Alzheimer's disease.
  • G Medical Innovations Holdings Ltd (NASDAQ: GMVD) shares gained 36.3% to $0.2590 after falling over 7% on Monday.
  • Siyata Mobile Inc. (NASDAQ: SYTA) shares rose 28.3% to $4.2599 following upbeat quarterly sales.
  • Wearable Devices Ltd. (NASDAQ: WLDS) jumped 23% to $1.40 after the company completed first manufacturing batch of the Mudra Band for Apple Watch.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 22.4% to $2.6812 after the company posted strong quarterly sales and announced leadership changes.
  • The Arena Group Holdings, Inc. (NYSE: AREN) shares gained 19.5% to $4.0399 after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
  • Pharvaris N.V. (NASDAQ: PHVS) gained 19.4% to $22.00 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $34.
  • LL Flooring Holdings, Inc. (NYSE: LL) shares climbed 18.9% to $4.46 after the company’s board announced exploration of strategic alternatives, including a sale.
  • Paysafe Limited (NYSE: PSFE) gained 18.9% to $14.05. Paysafe reported second-quarter FY23 revenue growth of 6% year-over-year to $402.338 million, beating the consensus of $394.16 million.
  • Taylor Devices, Inc. (NASDAQ: TAYD) rose 18.6% to $22.01 following fourth-quarter results.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares gained 18% to $0.46 after jumping 15% on Monday.
  • Fifth Wall Acquisition Corp. III (NASDAQ: FWAC) climbed 17.7% to $9.00.
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 16.2% to $1.47 following a narrower-than-expected quarterly loss..
  • Healthcare Triangle, Inc. (NASDAQ: HCTI) jumped 13.6% to $4.0231.
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 13.4% to $1.4350 after posting a narrower-than-expected loss.
  • Castellum, Inc. (NYSE: CTM) rose 12.4% to $0.5397 after posting better-than-expected quarterly sales.
  • TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) gained 10.8% to $0.4790 after the company reported second-quarter results and priced $5 million public offering of common stock.
  • SomaLogic, Inc. (NASDAQ: SLGC) rose 10.6% to $2.2450 after the company reported better-than-expected second-quarter financial results and issued guidance.
  • NextDecade Corporation (NASDAQ: NEXT) gained 10.3% to $6.10. Stifel upgraded NextDecade from Hold to Buy and raised the price target from $7.5 to $9.
  • 2seventy bio, Inc. (NASDAQ: TSVT) rose 7.4% to $6.47 following second-quarter results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • F45 Training Holdings Inc. (NYSE: FXLV) shares fell 75.9% to $0.1743 after the company announced it intends to voluntarily delist and deregister its securities.
  • Design Therapeutics, Inc. (NASDAQ: DSGN) fell 68.6% to $2.30 after the company reported initial results from its Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich ataxia. The company said there were injection site reactions.
  • Galecto, Inc. (NASDAQ: GLTO) fell 68% to $0.75 after the company announced topline results from its Phase 2b GALACTIC-1 trial of GB0139 for idiopathic pulmonary fibrosis, which showed the trial did not meet its primary endpoint. The company plans to discontinue development of GB0139.
  • Altisource Asset Management Corporation (NYSE: AAMC) shares fell 67.3% to $10.75 after the company posted a wider second-quarter loss.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) shares fell 64.4% to $0.1395 after posting a loss for the second quarter.
  • MGO Global, Inc. (NASDAQ: MGOL) fell 45.1% to $1.24 after the company reported second quarter financial results.
  • Assure Holdings Corp. (NASDAQ: IONM) fell 42.2% to $0.3688 following second-quarter results.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) fell 39.7% to $0.6086 following weak quarterly sales.
  • China Liberal Education Holdings Limited (NASDAQ: CLEU) declined 37.7% to $0.4797.
  • ADDvantage Technologies Group, Inc. (NASDAQ: AEY) fell 35.1% to $0.3755 following a wider quarterly loss.
  • Troika Media Group, Inc. (NASDAQ: TRKA) fell 30% to $1.3744. Troika Media said that the company has terminated employment of CEO, CFO effective Aug. 14.
  • OptimizeRx Corporation (NASDAQ: OPRX) shares fell 29% to $8.87 after posting weak quarterly sales.
  • Sea Limited (NYSE: SE) fell 28% to $41.01 following weaker-than-expected quarterly results.
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) fell 25.7% to $0.2098.
  • Nogin, Inc. (NASDAQ: NOGN) declined 23.5% to $0.7495 after the company reported worse-than-expected second-quarter financial results and issued FY23 revenue guidance below estimates.
  • Eastside Distilling, Inc. (NASDAQ: EAST) fell 22.3% to $2.33 following second-quarter results.
  • PhenomeX Inc. (NASDAQ: CELL) fell 19.9% to $0.4875 following weak second-quarter results.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) fell 19.7% to $0.1947 after the company announced ADS ratio change.
  • Proterra Inc. (NASDAQ: PTRA) declined 18.9% to $0.0935.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) fell 15.6% to $0.27.
  • XWELL, Inc. (NASDAQ: XWEL) fell 15.2% to $0.1950 following second-quarter results.
  • Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) fell 15% to $3.1525. Citigroup downgraded Gol Intelligent Airlines from Buy to Neutral.
  • 2U, Inc. (NASDAQ: TWOU) fell 13.6% to $3.3750.
  • On Holding AG (NYSE: ONON) fell 13.3% to $29.97 after the company reported mixed quarterly financial results.
  • Rigetti Computing, Inc. (NASDAQ: RGTI) fell 12.7% to $2.33.
  • Hanryu Holdings, Inc. (NASDAQ: HRYU) shares declined 12.5% to $5.92. Hanryu shares gained 45% on Tuesday after the company announced it partnered with SALTLUX for the development of an AI-powered conversational virtual assistant on K-culture fandom application.
  • Discover Financial Services (NYSE: DFS) shares fell 9.4% to $93.03 after it disclosed the resignation of Roger C. Hochschild as Chief Executive Officer (CEO) and President.
  • Calliditas Therapeutics AB (NASDAQ: CALT) shares fell 9.2% to $18.50 after the company announced full results from the NefIgArd Phase 3 trial published in The Lancet.
  • Farfetch Limited (NYSE: FTCH) fell 9.2% to $4.76.
  • Getty Images Holdings, Inc. (NYSE: GETY) fell 7.1% to $4.23 after the company reported second-quarter earnings.
  • Array Technologies, Inc. (NASDAQ: ARRY) declined 6.3% to $21.67.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Bitcoin Edges Higher Following Economic Data; Sei Emerges As Top Gainer

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.